Cancer-associated IDH mutations: biomarker and therapeutic opportunities (Q37802750)

23 August 2017

Cancer-associated IDH mutations: biomarker and therapeutic opportunities (English)

1 reference

23 August 2017

0 references

K E Yen

1

1 reference

23 August 2017

M A Bittinger

series ordinal

2

1 reference

23 August 2017

S M Su

series ordinal

3

1 reference

23 August 2017

V R Fantin

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

25 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

29

1 reference

23 August 2017

49

1 reference

23 August 2017

6409-6417

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.444

23 August 2017

0 references

cites work

Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Localization of cytosolic NADP-dependent isocitrate dehydrogenase in the peroxisomes of rat liver cells: biochemical and immunocytochemical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Single-voxel MR spectroscopy and diffusion-weighted MRI in two patients with l-2-hydroxyglutaric aciduria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Analysis of the IDH1 codon 132 mutation in brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Mitochondrial mutations in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Crystal structure of porcine mitochondrial NADP+-dependent isocitrate dehydrogenase complexed with Mn2+ and isocitrate. Insights into the enzyme mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Oncogenic alterations of metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 mutations in gliomas: when an enzyme loses its grip

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Hypoxia and adaptive landscapes in the evolution of carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDP3 encodes a peroxisomal NADP-dependent isocitrate dehydrogenase required for the beta-oxidation of unsaturated fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

The fundamental role of epigenetic events in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Oxidation of gamma-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent enzyme.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Tumor cell metabolism: cancer's Achilles' heel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Metabolism of 2-amino-5-hydroxyadipic acid in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Expanding chemical biology of 2-oxoglutarate oxygenases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Recurring mutations found by sequencing an acute myeloid leukemia genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

An integrated genomic analysis of human glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

L-2-hydroxyglutaric aciduria, a defect of metabolite repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

L-2 hydroxyglutaric aciduria: proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

The consensus coding sequences of human breast and colorectal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Peroxisomal beta-oxidation of polyunsaturated fatty acids in Saccharomyces cerevisiae: isocitrate dehydrogenase provides NADPH for reduction of double bonds at even positions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Understanding the Warburg effect: the metabolic requirements of cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Targeting the epidermal growth factor receptor in high-grade astrocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

The multistep nature of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

IDH1 and IDH2 mutations in gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.444

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.444

1 reference

23 August 2017

1 reference